Ledger.Open graph →
SEC Form D · filed December 15, 2015

BioQ Pharma Inc

Offering
$20.0M
Sold
$12.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Ron W. Pauli · San Francisco, CAExecJoshua W. Kriesel · San Francisco, CAExec · DirectorLlew J. Keltner · San Francisco, CADirectorDaniel J. Tasse · San Francisco, CADirectorChristopher J. Portman · San Francisco, CADirectorNorvall W. Jasper, Jr · San Francisco, CADirectorMark J. Ehlert · San Francisco, CADirectorRichard J. Nesbit · San Francisco, CADirectorMichael T. Lassner · PORTLAND, ORExecCharles M. Stucke · New York, NYDirectorMargaret T. Mccue · MANNEDORF, V8DirectorJoshua M. Fremed · New York, NYDirectorRyan M. Tie · New York, NYDirectorCathy T. Roe · SEATTLE, WADirectorOmniQuest Capital, LLC · Los Angeles, CADirectorJeffrey S. Davidson · Bloomfield Hills, MIExec · DirectorCharles C. Hibben · Bloomfield Hills, MIDirectorCarl G. De Rozario · Bloomfield Hills, MIDirectorPhilip Hilal · New York, NYDirectorMatt Auriemma · George Town, Grand Cayman, Cayman IslandsDirectorLouis R. Nagy · Aurora, Ontario, CanadaDirectorJean-Pierre I. Janson · Aurora, Ontario, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗